NC
BSTC

Northpointe Capital’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Northpointe Capital’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-16,396
Closed -$994K – 178
2018
Q4 		$994K Buy
+16,396
New +$980K 0.22% 152
2018
Q1 		– Sell
-80,710
Closed -$3.5M – 202
2017
Q4 		$3.5M Sell
80,710
-54,947
-41% -$2.47M 0.39% 107
2017
Q3 		$6.31M Buy
135,657
+26,013
+24% +$1.25M 0.67% 53
2017
Q2 		$5.43M Sell
109,644
-13,508
-11% -$708K 0.57% 70
2017
Q1 		$6.75M Sell
123,152
-4,125
-3% -$218K 0.74% 47
2016
Q4 		$7.09M Buy
127,277
+3,575
+3% +$172K 0.71% 51
2016
Q3 		$5.65M Buy
+123,702
New +$4.97M 0.59% 59
2015
Q3 		– Sell
-46,903
Closed -$2.42M – 211
2015
Q2 		$2.42M Sell
46,903
-76,861
-62% -$3.28M 0.28% 129
2015
Q1 		$4.84M Buy
123,764
+37,362
+43% +$1.46M 0.52% 60
2014
Q4 		$3.34M Buy
86,402
+38,545
+81% +$1.47M 0.4% 84
2014
Q3 		$1.69M Sell
47,857
-19,800
-29% -$581K 0.18% 153
2014
Q2 		$1.82M Sell
67,657
-28,543
-30% -$744K 0.18% 164
2014
Q1 		$2.49M Sell
96,200
-46,015
-32% -$1.1M 0.25% 93
2013
Q4 		$3.08M Buy
142,215
+40,890
+40% +$837K 0.27% 90
2013
Q3 		$1.97M Buy
+101,325
New +$1.8M 0.23% 110

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Northpointe Capital's BSTC Position: Q1 2019 in Review

Northpointe Capital sold out of BioSpecifics Technologies Corp. (BSTC) in Q1 2019, closing a stake of 16,396 shares — an estimated $994K sold.

Northpointe Capital first reported a position in BSTC in Q3 2013 and held it in 15 quarters. The position peaked at $7.09M in Q4 2016. 117 funds tracked by Wall St. Rank hold BSTC as of Q1 2019.

  • Northpointe Capital reported no remaining BioSpecifics Technologies Corp. position as of Q1 2019 after selling out during the quarter.
  • Northpointe Capital sold 16,396 BioSpecifics Technologies Corp. shares in Q1 2019, an estimated $994K.
  • Northpointe Capital first reported a position in BioSpecifics Technologies Corp. in Q3 2013 and held it in 15 quarters.
  • Northpointe Capital's BioSpecifics Technologies Corp. position peaked at $7.09M in Q4 2016.
  • 117 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q1 2019.

Based on Northpointe Capital's 13F filing for Q1 2019, filed 17 Apr 2019.